Abbott Laboratories

Type
Internal restructuring
Country
Ireland
Region
Ireland; Southern; Mid-West
Location of affected unit(s)
Tipperary
Sector
Manufacturing
(26 - 27) Manufacture of electrical, electronic and optical products
26.6 - Manufacture of irradiation, electromedical and electrotherapeutic equipment
26.6 - Manufacture of irradiation, electromedical and electrotherapeutic equipment
200 jobs
Number of planned job losses
Job loss
Announcement Date
20 February 2013
Employment effect (start)
20 March 2013
Foreseen end date
31 December 2013

Description

Abbott Laboratories, American global pharmaceuticals and health care products company, is to make approximately 200 staff redundant at its plant in Clonmel, County Tipperary. It is understood that staff will be made redundant at its vascular manufacturing facility. The management states that the restructuring is necessary in order to remain competitive.

Redundancies are expected to be implemented after a 30-day consultation period. The company hopes to implement the redundancies on a voluntary basis.

Abbott employs 1,400 people in Clonmel. 

Sources

  • 21 February 2013: The Irish Times

Citation

Eurofound (2013), Abbott Laboratories, Internal restructuring in Ireland, factsheet number 75030, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/75030.